Trevi Therapeutics CEO Jennifer Good's 2023 pay jumps 88% to $1.7M
Trevi Therapeutics reports 2023 executive compensation
By ExecPay News
Published: April 26, 2024
Trevi Therapeutics reported fiscal year 2023 executive compensation information on April 26, 2024.
In 2023, three executives at Trevi Therapeutics received on average a compensation package of $1.1M, a 59% increase compared to previous year.
Average pay of disclosed executives at Trevi Therapeutics
Jennifer Good, Chief Executive Officer, received $1.7M in total, which increased by 88% compared to 2022. 50% of Good's compensation, or $851K, was in option awards. Good also received $229K in bonus, $597K in salary, as well as $9.9K in other compensation.
Thomas Sciascia, Chief Scientific Officer, received a compensation package of $977K, which increased by 69% compared to previous year. 44% of the compensation package, or $426K, was in option awards.
David J. Clark, Chief Medical Officer, earned $611K in 2023, a 5% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 26, 2024.